Back to mobile site

Uroplasty, Inc. (UPI) Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation

May 30, 2013 4:17 PM EDT Send to a Friend
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login